We are live on
!
Find out more
ROTUOC
Regents of the University of California Portfolio holdings
AUM
$4.36B
1-Year Est. Return
33.89%
This Fund
S&P 500
This Quarter
Est. Return
+3.88%
1 Year Est. Return
+33.89%
3 Year Est. Return
+86.09%
5 Year Est. Return
+63.96%
10 Year Est. Return
+870.04%
AUM
$692M
AUM Growth
-$26.8M
(-3.7%)
Cap. Flow
-$38.6M
Cap. Flow
% of AUM
-5.58%
Top 10 Holdings %
Top 10 Hldgs %
97.33%
Holding
33
New
4
Increased
–
Reduced
3
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$49.2M |
| 2 |
Allogene Therapeutics
ALLO
|
+$29.3M |
| 3 |
Revolution Medicines
RVMD
|
+$5.54M |
| 4 |
NARI
Inari Medical, Inc. Common Stock
NARI
|
+$293K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$98.9M |
| 2 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
+$12.6M |
| 3 |
RAPT
RAPT Therapeutics
RAPT
|
+$7.03M |
| 4 |
Bloom Energy
BE
|
+$3.15M |
| 5 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$768K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 78.79% |
| 2 | Healthcare | 12.07% |
| 3 | Consumer Discretionary | 5.95% |
| 4 | Consumer Staples | 1.43% |
| 5 | Materials | 0.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Blue Owl Capital
OBDC
$5.81B
| $540M | 78.07% |
42,690,843
| – | – |
|
|
2
Alibaba
BABA
$297B
| $41.2M | 5.95% |
+177,072
| New | +$49.2M |
|
|
3
Allogene Therapeutics
ALLO
$708M
| $22.7M | 3.28% |
+900,143
| New | +$29.3M |
|
|
RAPT
4
DELISTED
RAPT Therapeutics
RAPT
| $22.2M | 3.2% |
140,280
-32,308
| -19% | -$7.03M |
|
|
CNST
5
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $21.2M | 3.07% |
737,406
-500,000
| -40% | -$12.6M |
|
6
Estee Lauder
EL
$31.6B
| $8.89M | 1.28% |
33,400
| – | – |
|
7
Intellia Therapeutics
NTLA
$1.68B
| $6.06M | 0.88% |
111,440
| – | – |
|
|
8
Revolution Medicines
RVMD
$44.1B
| $5.55M | 0.8% |
+140,155
| New | +$5.54M |
|
9
Air Products & Chemicals
APD
$68B
| $2.79M | 0.4% |
10,200
| – | – |
|
|
ORTX
10
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $2.68M | 0.39% |
62,023
| – | – |
|
11
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.3B
| $2.35M | 0.34% |
5,600
| – | – |
|
12
S&P Global
SPGI
$123B
| $1.97M | 0.28% |
6,000
| – | – |
|
13
Berkshire Hathaway Class B
BRK.B
$1.09T
| $1.86M | 0.27% |
8,043
| – | – |
|
14
Merck
MRK
$330B
| $1.77M | 0.26% |
22,637
| – | – |
|
15
ExxonMobil
XOM
$652B
| $1.39M | 0.2% |
33,600
| – | – |
|
16
Walt Disney
DIS
$180B
| $1.09M | 0.16% |
6,000
| – | – |
|
17
Texas Instruments
TXN
$255B
| $1.07M | 0.15% |
6,500
| – | – |
|
18
Verizon
VZ
$196B
| $1.04M | 0.15% |
17,735
| – | – |
|
19
Pfizer
PFE
$151B
| $1.02M | 0.15% |
27,645
-1,493
| -5% | -$54.8K |
|
20
Coca-Cola
KO
$374B
| $987K | 0.14% |
18,000
| – | – |
|
21
Honeywell
HON
$74.3B
| $898K | 0.13% |
4,481
| – | – |
|
22
AT&T
T
$167B
| $624K | 0.09% |
28,715
| – | – |
|
|
MRSH
23
Marsh
MRSH
$91B
| $608K | 0.09% |
5,200
| – | – |
|
24
Wells Fargo
WFC
$269B
| $546K | 0.08% |
18,106
| – | – |
|
25
GE Aerospace
GE
$377B
| $433K | 0.06% |
8,041
| – | – |
|
Similar funds
SFM
EC
EQF
NEI
FIS
CAU
IUHSA
CW
Regents of the University of California's Q4 2020 Portfolio in Review
As of Q4 2020, Regents of the University of California held 33 positions worth $692M, down 3.7% from $719M the previous quarter. Its ten largest holdings account for 97% of the portfolio.
Regents of the University of California withdrew a net $38.6M in Q4 2020, closing 5 positions and reducing 3 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $98.9M position sold in full.
By sector, the portfolio is most concentrated in Financials at 79% of assets, up from 72% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Regents of the University of California opened a new position in Alibaba worth $41.2M.
- Regents of the University of California's largest Q4 2020 buy was Alibaba: 177,072 shares worth $41.2M.
- Regents of the University of California's biggest Q4 2020 reduction was Constellation Pharmaceuticals, Inc., cutting an estimated $12.6M.
- Regents of the University of California fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q4 2020, selling an estimated $98.9M.
- Regents of the University of California's ten largest holdings make up 97% of its $692M portfolio in Q4 2020.
- Regents of the University of California opened 4 new positions and closed 5 in Q4 2020.
- Regents of the University of California's portfolio value fell 3.7% quarter-over-quarter to $692M.
Based on Regents of the University of California's 13F filing for Q4 2020, filed 21 Jan 2021.